Biotest AG
Biotest AG (BTTAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTTAY · as of Jun 8, 2026
Key Statistics
Explore Biotest AG Data
bttay stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bttay competitorsBTTAY
CKDXF
CLAZF
CSWYF
EBRCZ
IVEVFStock Performance
Full HistoryAbout Biotest AG
Biotest AG Operating globally from its headquarters in Dreieich, Germany, Biotest AG is a pharmaceutical company established in 1946. It specializes in the research, development, manufacturing, and commercializa…
what is biotest ag · bttay stock overview · biotest ag company profile · who is biotest ag ceo · bttay OTC · biotest ag headquarters · biotest ag business segments
About Stock Overview & Key Data
Biotest AG (BTTAY) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 8, 2022. As of the latest trading session, BTTAY stock price is $24.23, with a market capitalization of $943.0M. The stock has returned -0.16% over the past 12 months and -0.16% year-to-date.
In fiscal year 2024, Biotest AG reported revenue of $726.2M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biotest AG (BTTAY) stock price is $24.23. The stock is traded on OTC under the ticker symbol BTTAY. The 52-week range is $22.80 – $24.27.